The acetylation-defective mutant p53(3KR) maintains the ability to repress SLC7A11 expression and to induce ferroptosis upon oxidative stress, which may explain, at least in part, the tumor suppressive phenotype observed in p53(3KR) mice. This evidence concerns the gene TP53 and neoplasm.